People with a hidden heart condition may be at risk because current medical guidelines don't consider important personal ...

Mount Sinai's AI-powered ECG tool now predicts individual risk for hypertrophic cardiomyopathy (HCM), enabling faster ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has given the green light to acoramidis (Beyonttra) for adult ...

Researchers have calibrated an AI algorithm to more specifically identify patients with hypertrophic cardiomyopathy (HCM), a ...

Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an ...

A new study led by researchers at The Ohio State University Wexner Medical Center and College of Medicine found that heavy ...